“The CRISPR-IL consortium will enable Israeli industry to be at the forefront of genome editing worldwide."
By JNi.Media
A potential future use of iPSCs is the creation of whole organs (such as heart, liver or kidney) in a suitable animal model using cells taken from the patient.
